"REBIRTH active school" - effects of a school-based mobility program on sustained health benefits for pupils.

"REBIRTH active school" - effects of a school-based mobility program on sustained health benefits for pupils. - REBIRTH active school

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012371

Enrollment

400

Registered

2017-08-18

Start date

2017-03-24

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular morbidity

Interventions

Group 1: Pupils from classes participating in the mobility program shall be included. The mobility program consists of a short mobility break within each lesson, as well as a 30 minute long exercise

Eligibility

Sex/Gender

All

Age

6 Years to 19 Years

Inclusion criteria

Inclusion criteria: Second and fifth grade pupils, whose schools participates in the Rebirth active School mobility program.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Telomere length of DNA from peripheral mononuclear cells (measured by PCR (polymerase chain reaction)) at inclusion, after 1 year and after 2 years.	—

Secondary

Measure	Time frame
The followig prameters will be analyzed as secondary endpoints at inclusion, after 1year, and after 2 years: Pulse wave velocity will be measured oscillometrically by using the Vicorder device, which is validated for pediatric use. Intima-media thickness will be measured by ultrasound, employing the guidelines of the Mannheim Consensus. p16INK4a-Expression will be determined by RT-PCR in peripheral mononuclear cells.	—

Measure

Time frame

The followig prameters will be analyzed as secondary endpoints at inclusion, after 1year, and after 2 years: Pulse wave velocity will be measured oscillometrically by using the Vicorder device, which is validated for pediatric use. Intima-media thickness will be measured by ultrasound, employing the guidelines of the Mannheim Consensus. p16INK4a-Expression will be determined by RT-PCR in peripheral mononuclear cells.

—

Countries

Germany

Contacts

Public ContactAnette Melk

Klinik für Pädiatrische Nieren-, Leber- und StoffwechselerkrankungenMedizinische Hochschule Hannover

melk.anette@mh-hannover.de05115325597

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026